nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—epiphyseal plate—sarcoma	0.0959	0.132	CbGeAlD
Amifostine—ALPPL2—forelimb zeugopod—sarcoma	0.0768	0.106	CbGeAlD
Amifostine—ALPPL2—mandible—sarcoma	0.0761	0.105	CbGeAlD
Amifostine—ALPPL2—periosteum—sarcoma	0.0488	0.0672	CbGeAlD
Amifostine—ALPPL2—skull—sarcoma	0.0401	0.0552	CbGeAlD
Amifostine—ALPPL2—leg—sarcoma	0.0389	0.0536	CbGeAlD
Amifostine—ALPPL2—forelimb—sarcoma	0.0386	0.0532	CbGeAlD
Amifostine—ALPPL2—hindlimb—sarcoma	0.0348	0.0478	CbGeAlD
Amifostine—ALPPL2—cartilage tissue—sarcoma	0.0342	0.0471	CbGeAlD
Amifostine—ALPPL2—arm—sarcoma	0.0332	0.0457	CbGeAlD
Amifostine—ALPPL2—appendage—sarcoma	0.0298	0.041	CbGeAlD
Amifostine—ALPPL2—endothelium—sarcoma	0.018	0.0248	CbGeAlD
Amifostine—ALPL—mammary gland—sarcoma	0.0164	0.0226	CbGeAlD
Amifostine—ENPP1—mammary gland—sarcoma	0.015	0.0207	CbGeAlD
Amifostine—ALPL—AGE/RAGE pathway—EZR—sarcoma	0.0114	0.166	CbGpPWpGaD
Amifostine—ALPPL2—embryo—sarcoma	0.0099	0.0136	CbGeAlD
Amifostine—ENPP1—hematopoietic system—sarcoma	0.00917	0.0126	CbGeAlD
Amifostine—ALPPL2—hematopoietic system—sarcoma	0.00884	0.0122	CbGeAlD
Amifostine—ENPP1—connective tissue—sarcoma	0.00883	0.0121	CbGeAlD
Amifostine—ALPPL2—connective tissue—sarcoma	0.00851	0.0117	CbGeAlD
Amifostine—Respiratory arrest—Thiotepa—sarcoma	0.00835	0.0408	CcSEcCtD
Amifostine—ENPP1—skin of body—sarcoma	0.00797	0.011	CbGeAlD
Amifostine—ALPPL2—skin of body—sarcoma	0.00768	0.0106	CbGeAlD
Amifostine—ENPP1—uterus—sarcoma	0.00693	0.00953	CbGeAlD
Amifostine—ALPPL2—uterus—sarcoma	0.00668	0.00919	CbGeAlD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—sarcoma	0.0063	0.0917	CbGpPWpGaD
Amifostine—ALPPL2—lymphoid tissue—sarcoma	0.00622	0.00856	CbGeAlD
Amifostine—ENPP1—tendon—sarcoma	0.00607	0.00835	CbGeAlD
Amifostine—ALPPL2—bone marrow—sarcoma	0.00567	0.0078	CbGeAlD
Amifostine—ALPL—testis—sarcoma	0.00547	0.00753	CbGeAlD
Amifostine—ALPL—liver—sarcoma	0.00517	0.00712	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—IGF1R—sarcoma	0.00503	0.0732	CbGpPWpGaD
Amifostine—ENPP1—testis—sarcoma	0.00502	0.00691	CbGeAlD
Amifostine—ALPPL2—testis—sarcoma	0.00484	0.00666	CbGeAlD
Amifostine—ENPP1—liver—sarcoma	0.00475	0.00654	CbGeAlD
Amifostine—ALPL—AGE/RAGE pathway—FOXO1—sarcoma	0.00467	0.068	CbGpPWpGaD
Amifostine—ALPPL2—liver—sarcoma	0.00458	0.0063	CbGeAlD
Amifostine—ENPP1—Endochondral Ossification—IGF1R—sarcoma	0.00428	0.0622	CbGpPWpGaD
Amifostine—Hypocalcaemia—Dactinomycin—sarcoma	0.00398	0.0195	CcSEcCtD
Amifostine—ALPL—lymph node—sarcoma	0.00397	0.00546	CbGeAlD
Amifostine—Myocardial ischaemia—Mitoxantrone—sarcoma	0.00395	0.0193	CcSEcCtD
Amifostine—ENPP1—lymph node—sarcoma	0.00364	0.00501	CbGeAlD
Amifostine—ALPL—BDNF signaling pathway—PLCG1—sarcoma	0.00353	0.0513	CbGpPWpGaD
Amifostine—Hypocalcaemia—Mitoxantrone—sarcoma	0.00347	0.0169	CcSEcCtD
Amifostine—Rigors—Etoposide—sarcoma	0.00323	0.0158	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—sarcoma	0.00315	0.0459	CbGpPWpGaD
Amifostine—Apnoea—Etoposide—sarcoma	0.00311	0.0152	CcSEcCtD
Amifostine—Chest discomfort—Etoposide—sarcoma	0.00298	0.0146	CcSEcCtD
Amifostine—Cardiac arrest—Thiotepa—sarcoma	0.00254	0.0124	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—JUN—sarcoma	0.00244	0.0354	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00238	0.0117	CcSEcCtD
Amifostine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00238	0.0116	CcSEcCtD
Amifostine—Cardiac arrest—Vincristine—sarcoma	0.00225	0.011	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—SRC—sarcoma	0.00219	0.0318	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—sarcoma	0.00218	0.0317	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IGF1R—sarcoma	0.00205	0.0299	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00202	0.00989	CcSEcCtD
Amifostine—Renal failure—Thiotepa—sarcoma	0.00202	0.00988	CcSEcCtD
Amifostine—Anaphylactoid reaction—Etoposide—sarcoma	0.00198	0.00968	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—FOXO1—sarcoma	0.00196	0.0285	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—sarcoma	0.00192	0.0279	CbGpPWpGaD
Amifostine—Feeling hot—Epirubicin—sarcoma	0.00188	0.00922	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—sarcoma	0.00185	0.027	CbGpPWpGaD
Amifostine—Cardiac arrest—Etoposide—sarcoma	0.00182	0.00891	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CREB1—sarcoma	0.00181	0.0264	CbGpPWpGaD
Amifostine—Rigors—Epirubicin—sarcoma	0.00181	0.00886	CcSEcCtD
Amifostine—Acute coronary syndrome—Vincristine—sarcoma	0.0018	0.00878	CcSEcCtD
Amifostine—Myocardial infarction—Vincristine—sarcoma	0.00179	0.00873	CcSEcCtD
Amifostine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00175	0.00855	CcSEcCtD
Amifostine—Renal failure—Mitoxantrone—sarcoma	0.00174	0.00853	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—sarcoma	0.00174	0.00853	CcSEcCtD
Amifostine—Myocardial infarction—Mitoxantrone—sarcoma	0.00174	0.00851	CcSEcCtD
Amifostine—Erythema multiforme—Dactinomycin—sarcoma	0.00173	0.00847	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00173	0.00843	CcSEcCtD
Amifostine—Flushing—Dactinomycin—sarcoma	0.0017	0.00831	CcSEcCtD
Amifostine—Rigors—Doxorubicin—sarcoma	0.00168	0.0082	CcSEcCtD
Amifostine—Chills—Thiotepa—sarcoma	0.00166	0.00809	CcSEcCtD
Amifostine—Arrhythmia—Thiotepa—sarcoma	0.00165	0.00806	CcSEcCtD
Amifostine—Chills—Dactinomycin—sarcoma	0.00164	0.00803	CcSEcCtD
Amifostine—Bradycardia—Mitoxantrone—sarcoma	0.00162	0.00793	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—sarcoma	0.00162	0.0079	CcSEcCtD
Amifostine—Hypocalcaemia—Doxorubicin—sarcoma	0.0015	0.00731	CcSEcCtD
Amifostine—Hiccups—Epirubicin—sarcoma	0.00148	0.00723	CcSEcCtD
Amifostine—Ill-defined disorder—Dactinomycin—sarcoma	0.00148	0.00723	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00146	0.00716	CcSEcCtD
Amifostine—Acute coronary syndrome—Etoposide—sarcoma	0.00146	0.00712	CcSEcCtD
Amifostine—Renal failure—Etoposide—sarcoma	0.00145	0.0071	CcSEcCtD
Amifostine—Myocardial infarction—Etoposide—sarcoma	0.00145	0.00708	CcSEcCtD
Amifostine—Malaise—Dactinomycin—sarcoma	0.00144	0.00703	CcSEcCtD
Amifostine—Chills—Mitoxantrone—sarcoma	0.00143	0.00699	CcSEcCtD
Amifostine—Arrhythmia—Mitoxantrone—sarcoma	0.00142	0.00696	CcSEcCtD
Amifostine—Convulsion—Thiotepa—sarcoma	0.00139	0.0068	CcSEcCtD
Amifostine—Hypertension—Thiotepa—sarcoma	0.00139	0.00678	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—sarcoma	0.00137	0.00669	CcSEcCtD
Amifostine—Discomfort—Dactinomycin—sarcoma	0.00134	0.00656	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—JUN—sarcoma	0.00131	0.019	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—sarcoma	0.0013	0.0188	CbGpPWpGaD
Amifostine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00129	0.00629	CcSEcCtD
Amifostine—Tachycardia—Thiotepa—sarcoma	0.00128	0.00626	CcSEcCtD
Amifostine—Erythema multiforme—Etoposide—sarcoma	0.00125	0.00613	CcSEcCtD
Amifostine—Malaise—Mitoxantrone—sarcoma	0.00125	0.00612	CcSEcCtD
Amifostine—Convulsion—Vincristine—sarcoma	0.00123	0.00603	CcSEcCtD
Amifostine—Flushing—Etoposide—sarcoma	0.00123	0.00601	CcSEcCtD
Amifostine—Hypertension—Vincristine—sarcoma	0.00123	0.00601	CcSEcCtD
Amifostine—Convulsion—Mitoxantrone—sarcoma	0.0012	0.00588	CcSEcCtD
Amifostine—Hypertension—Mitoxantrone—sarcoma	0.0012	0.00586	CcSEcCtD
Amifostine—Chills—Etoposide—sarcoma	0.00119	0.00581	CcSEcCtD
Amifostine—Chest pain—Mitoxantrone—sarcoma	0.00118	0.00577	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—SRC—sarcoma	0.00117	0.017	CbGpPWpGaD
Amifostine—Discomfort—Mitoxantrone—sarcoma	0.00117	0.0057	CcSEcCtD
Amifostine—Somnolence—Thiotepa—sarcoma	0.00117	0.0057	CcSEcCtD
Amifostine—Anaphylactic shock—Vincristine—sarcoma	0.00116	0.00568	CcSEcCtD
Amifostine—Dermatitis exfoliative—Epirubicin—sarcoma	0.00114	0.00556	CcSEcCtD
Amifostine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00113	0.00553	CcSEcCtD
Amifostine—Shock—Mitoxantrone—sarcoma	0.00111	0.00545	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00111	0.00542	CcSEcCtD
Amifostine—Tachycardia—Mitoxantrone—sarcoma	0.0011	0.0054	CcSEcCtD
Amifostine—Hypotension—Vincristine—sarcoma	0.00109	0.00531	CcSEcCtD
Amifostine—Feeling abnormal—Thiotepa—sarcoma	0.00108	0.00528	CcSEcCtD
Amifostine—Feeling abnormal—Dactinomycin—sarcoma	0.00107	0.00524	CcSEcCtD
Amifostine—Ill-defined disorder—Etoposide—sarcoma	0.00107	0.00523	CcSEcCtD
Amifostine—Hypotension—Mitoxantrone—sarcoma	0.00106	0.00517	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00105	0.00515	CcSEcCtD
Amifostine—Urticaria—Thiotepa—sarcoma	0.00104	0.00509	CcSEcCtD
Amifostine—Malaise—Etoposide—sarcoma	0.00104	0.00509	CcSEcCtD
Amifostine—Body temperature increased—Thiotepa—sarcoma	0.00104	0.00507	CcSEcCtD
Amifostine—Body temperature increased—Dactinomycin—sarcoma	0.00103	0.00503	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00103	0.00502	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—sarcoma	0.00102	0.00499	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—JUN—sarcoma	0.00102	0.0148	CbGpPWpGaD
Amifostine—Loss of consciousness—Etoposide—sarcoma	0.00101	0.00496	CcSEcCtD
Amifostine—Dyspnoea—Mitoxantrone—sarcoma	0.00101	0.00493	CcSEcCtD
Amifostine—Somnolence—Mitoxantrone—sarcoma	0.00101	0.00492	CcSEcCtD
Amifostine—Convulsion—Etoposide—sarcoma	0.001	0.00489	CcSEcCtD
Amifostine—Hypertension—Etoposide—sarcoma	0.000996	0.00487	CcSEcCtD
Amifostine—Chest pain—Etoposide—sarcoma	0.000982	0.0048	CcSEcCtD
Amifostine—Discomfort—Etoposide—sarcoma	0.00097	0.00474	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000967	0.00473	CcSEcCtD
Amifostine—Hypersensitivity—Thiotepa—sarcoma	0.000966	0.00472	CcSEcCtD
Amifostine—Hypersensitivity—Dactinomycin—sarcoma	0.000958	0.00469	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—sarcoma	0.000945	0.00462	CcSEcCtD
Amifostine—Anaphylactic shock—Etoposide—sarcoma	0.000942	0.0046	CcSEcCtD
Amifostine—Feeling abnormal—Mitoxantrone—sarcoma	0.000933	0.00456	CcSEcCtD
Amifostine—Pruritus—Thiotepa—sarcoma	0.000927	0.00453	CcSEcCtD
Amifostine—Tachycardia—Etoposide—sarcoma	0.000919	0.00449	CcSEcCtD
Amifostine—Body temperature increased—Vincristine—sarcoma	0.000919	0.00449	CcSEcCtD
Amifostine—Urticaria—Mitoxantrone—sarcoma	0.000899	0.0044	CcSEcCtD
Amifostine—Body temperature increased—Mitoxantrone—sarcoma	0.000895	0.00438	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000895	0.00437	CcSEcCtD
Amifostine—Hypotension—Etoposide—sarcoma	0.00088	0.0043	CcSEcCtD
Amifostine—Dizziness—Thiotepa—sarcoma	0.000867	0.00424	CcSEcCtD
Amifostine—Hypersensitivity—Vincristine—sarcoma	0.000856	0.00419	CcSEcCtD
Amifostine—Dyspnoea—Etoposide—sarcoma	0.000839	0.0041	CcSEcCtD
Amifostine—Somnolence—Etoposide—sarcoma	0.000837	0.00409	CcSEcCtD
Amifostine—Hypersensitivity—Mitoxantrone—sarcoma	0.000834	0.00408	CcSEcCtD
Amifostine—Vomiting—Thiotepa—sarcoma	0.000833	0.00407	CcSEcCtD
Amifostine—Vomiting—Dactinomycin—sarcoma	0.000827	0.00404	CcSEcCtD
Amifostine—Rash—Thiotepa—sarcoma	0.000826	0.00404	CcSEcCtD
Amifostine—Dermatitis—Thiotepa—sarcoma	0.000826	0.00404	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—sarcoma	0.000824	0.012	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00082	0.00401	CcSEcCtD
Amifostine—Rash—Dactinomycin—sarcoma	0.00082	0.00401	CcSEcCtD
Amifostine—Renal failure—Epirubicin—sarcoma	0.000813	0.00398	CcSEcCtD
Amifostine—ENPP1—Disease—TLE1—sarcoma	0.000801	0.0117	CbGpPWpGaD
Amifostine—Nausea—Thiotepa—sarcoma	0.000779	0.00381	CcSEcCtD
Amifostine—Feeling abnormal—Etoposide—sarcoma	0.000776	0.00379	CcSEcCtD
Amifostine—Nausea—Dactinomycin—sarcoma	0.000773	0.00378	CcSEcCtD
Amifostine—Dizziness—Vincristine—sarcoma	0.000769	0.00376	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000759	0.00371	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—sarcoma	0.000756	0.0037	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—sarcoma	0.000753	0.00368	CcSEcCtD
Amifostine—Urticaria—Etoposide—sarcoma	0.000748	0.00366	CcSEcCtD
Amifostine—Body temperature increased—Etoposide—sarcoma	0.000744	0.00364	CcSEcCtD
Amifostine—Vomiting—Vincristine—sarcoma	0.000739	0.00361	CcSEcCtD
Amifostine—Rash—Vincristine—sarcoma	0.000733	0.00358	CcSEcCtD
Amifostine—Dermatitis—Vincristine—sarcoma	0.000732	0.00358	CcSEcCtD
Amifostine—ENPP1—Disease—NPM1—sarcoma	0.000723	0.0105	CbGpPWpGaD
Amifostine—Vomiting—Mitoxantrone—sarcoma	0.00072	0.00352	CcSEcCtD
Amifostine—Rash—Mitoxantrone—sarcoma	0.000714	0.00349	CcSEcCtD
Amifostine—Dermatitis—Mitoxantrone—sarcoma	0.000713	0.00349	CcSEcCtD
Amifostine—Erythema multiforme—Epirubicin—sarcoma	0.000702	0.00343	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—sarcoma	0.0007	0.00342	CcSEcCtD
Amifostine—Hypersensitivity—Etoposide—sarcoma	0.000694	0.00339	CcSEcCtD
Amifostine—Nausea—Vincristine—sarcoma	0.00069	0.00338	CcSEcCtD
Amifostine—Flushing—Epirubicin—sarcoma	0.000689	0.00337	CcSEcCtD
Amifostine—Nausea—Mitoxantrone—sarcoma	0.000672	0.00329	CcSEcCtD
Amifostine—Chills—Epirubicin—sarcoma	0.000667	0.00326	CcSEcCtD
Amifostine—Pruritus—Etoposide—sarcoma	0.000666	0.00326	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—sarcoma	0.000664	0.00324	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—sarcoma	0.00065	0.00318	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—HRAS—sarcoma	0.000644	0.00937	CbGpPWpGaD
Amifostine—Flushing—Doxorubicin—sarcoma	0.000638	0.00312	CcSEcCtD
Amifostine—ENPP1—Disease—ENO2—sarcoma	0.000626	0.00911	CbGpPWpGaD
Amifostine—Dizziness—Etoposide—sarcoma	0.000623	0.00304	CcSEcCtD
Amifostine—Chills—Doxorubicin—sarcoma	0.000617	0.00302	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—sarcoma	0.000614	0.003	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—sarcoma	0.0006	0.00293	CcSEcCtD
Amifostine—Vomiting—Etoposide—sarcoma	0.000599	0.00293	CcSEcCtD
Amifostine—Rash—Etoposide—sarcoma	0.000594	0.0029	CcSEcCtD
Amifostine—Dermatitis—Etoposide—sarcoma	0.000593	0.0029	CcSEcCtD
Amifostine—Malaise—Epirubicin—sarcoma	0.000583	0.00285	CcSEcCtD
Amifostine—Syncope—Epirubicin—sarcoma	0.00058	0.00284	CcSEcCtD
Amifostine—Loss of consciousness—Epirubicin—sarcoma	0.000568	0.00278	CcSEcCtD
Amifostine—Convulsion—Epirubicin—sarcoma	0.00056	0.00274	CcSEcCtD
Amifostine—Nausea—Etoposide—sarcoma	0.000559	0.00273	CcSEcCtD
Amifostine—Hypertension—Epirubicin—sarcoma	0.000558	0.00273	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—sarcoma	0.000555	0.00271	CcSEcCtD
Amifostine—Chest pain—Epirubicin—sarcoma	0.000551	0.00269	CcSEcCtD
Amifostine—Discomfort—Epirubicin—sarcoma	0.000544	0.00266	CcSEcCtD
Amifostine—Malaise—Doxorubicin—sarcoma	0.00054	0.00264	CcSEcCtD
Amifostine—Syncope—Doxorubicin—sarcoma	0.000537	0.00262	CcSEcCtD
Amifostine—ENPP1—Disease—PLCG1—sarcoma	0.000531	0.00773	CbGpPWpGaD
Amifostine—Anaphylactic shock—Epirubicin—sarcoma	0.000528	0.00258	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—sarcoma	0.000526	0.00257	CcSEcCtD
Amifostine—ENPP1—Metabolism—ENO2—sarcoma	0.000524	0.00763	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HBA1—sarcoma	0.000521	0.00758	CbGpPWpGaD
Amifostine—Shock—Epirubicin—sarcoma	0.000519	0.00254	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—sarcoma	0.000518	0.00253	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—sarcoma	0.000517	0.00253	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—sarcoma	0.000515	0.00252	CcSEcCtD
Amifostine—ENPP1—Disease—CXCR4—sarcoma	0.00051	0.00742	CbGpPWpGaD
Amifostine—Chest pain—Doxorubicin—sarcoma	0.000509	0.00249	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—sarcoma	0.000503	0.00246	CcSEcCtD
Amifostine—Hypotension—Epirubicin—sarcoma	0.000493	0.00241	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—sarcoma	0.000488	0.00239	CcSEcCtD
Amifostine—Shock—Doxorubicin—sarcoma	0.00048	0.00235	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—sarcoma	0.000477	0.00233	CcSEcCtD
Amifostine—Dyspnoea—Epirubicin—sarcoma	0.000471	0.0023	CcSEcCtD
Amifostine—Somnolence—Epirubicin—sarcoma	0.000469	0.00229	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—sarcoma	0.000456	0.00223	CcSEcCtD
Amifostine—ENPP1—Metabolism—PLCG1—sarcoma	0.000445	0.00647	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—sarcoma	0.000435	0.00213	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—sarcoma	0.000435	0.00213	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—sarcoma	0.000434	0.00212	CcSEcCtD
Amifostine—Urticaria—Epirubicin—sarcoma	0.000419	0.00205	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—sarcoma	0.000417	0.00204	CcSEcCtD
Amifostine—Feeling abnormal—Doxorubicin—sarcoma	0.000402	0.00197	CcSEcCtD
Amifostine—Hypersensitivity—Epirubicin—sarcoma	0.000389	0.0019	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—sarcoma	0.000388	0.0019	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—sarcoma	0.000386	0.00189	CcSEcCtD
Amifostine—ENPP1—Disease—FOXO1—sarcoma	0.000377	0.00548	CbGpPWpGaD
Amifostine—ENPP1—Disease—PDGFRB—sarcoma	0.000376	0.00547	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—sarcoma	0.000373	0.00183	CcSEcCtD
Amifostine—ENPP1—Disease—PDGFRA—sarcoma	0.00037	0.00539	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—sarcoma	0.00036	0.00176	CcSEcCtD
Amifostine—Dizziness—Epirubicin—sarcoma	0.000349	0.00171	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—sarcoma	0.000346	0.00169	CcSEcCtD
Amifostine—Vomiting—Epirubicin—sarcoma	0.000336	0.00164	CcSEcCtD
Amifostine—Rash—Epirubicin—sarcoma	0.000333	0.00163	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—sarcoma	0.000332	0.00163	CcSEcCtD
Amifostine—Dizziness—Doxorubicin—sarcoma	0.000323	0.00158	CcSEcCtD
Amifostine—Nausea—Epirubicin—sarcoma	0.000313	0.00153	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—sarcoma	0.00031	0.00152	CcSEcCtD
Amifostine—Rash—Doxorubicin—sarcoma	0.000308	0.00151	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—sarcoma	0.000308	0.0015	CcSEcCtD
Amifostine—Nausea—Doxorubicin—sarcoma	0.00029	0.00142	CcSEcCtD
Amifostine—ENPP1—Disease—KIT—sarcoma	0.000287	0.00418	CbGpPWpGaD
Amifostine—ENPP1—Disease—CREB1—sarcoma	0.000273	0.00398	CbGpPWpGaD
Amifostine—ENPP1—Disease—MDM2—sarcoma	0.000226	0.00329	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTNNB1—sarcoma	0.000195	0.00284	CbGpPWpGaD
Amifostine—ENPP1—Disease—SRC—sarcoma	0.000176	0.00257	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRAS—sarcoma	0.00017	0.00247	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—sarcoma	0.000158	0.0023	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—sarcoma	0.000155	0.00225	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—sarcoma	0.000146	0.00212	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—sarcoma	0.000124	0.00181	CbGpPWpGaD
